RankAlpha logo
Back to Rankings

SIGA

SIGAD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
SIGA vs peer average
52/100
SIGA vs. peer average (D vs. D)
Grade spread
B 1 · C 2 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

FATE is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $319.37M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerFATEFate Therapeutics
SIGA
SIGA
FATE
Fate Therapeutics
Grade
D
F
Momentum
11
21
Value
73
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs FATE

SIGA / FATE
Grade Position
In line
SIGA vs. peer average (D vs. D)
52/100
Momentum
11
FATE
Value
73
SIGA
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SIGA
1
FATE
Fate Therapeutics Inc Common
F
20/100
+1
2
TENX
Tenax Therapeutics Inc Common
F
20/100
+1
3
ABEO
Abeona Therapeutics Inc Common
B
80/100
-2
4
BCYC
Bicycle Therapeutics Plc ADR
F
20/100
+1
5
HUMA
Humacyte Inc Common
F
20/100
+1
FATE is the first peer returned for this comparison set.